The Board of Directors of Otonomy (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Committee composition
Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
|
Member
|
||||
|---|---|---|---|---|
|
Jim Breitmeyer, M.D.
|
Compensation Committee | Research & Development Committee | ||
|
Jill Broadfoot
|
Audit Committee | |||
|
Vickie Capps
|
Audit Committee | Corporate Governance and Nominating Committee | ||
|
Ciara Kennedy, Ph.D.
|
Corporate Governance and Nominating Committee | Research & Development Committee | ||
|
Jay Lichter, Ph.D.
|
Compensation Committee | Research & Development Committee | ||
|
Iain McGill
|
Audit Committee | Corporate Governance and Nominating Committee | ||
|
Ted Schroeder
|
Compensation Committee |
= Chairperson
= Member
= Financial Expert